Article Versions Notes

Braschel C, Fabikan H, Rodriguez VM, Hochmair MJ, Illini O, Ay L, Weinlinger C, Krainer-Jacobs J, Müser N, Valipour A, et al. Clinical Impact of EGFR Mutation Subtypes on Treatment Outcomes in Advanced Non-Small Cell Lung Cancer: An Austrian Real-World Study. Cancers. 2026; 18(2):278. https://doi.org/10.3390/cancers18020278

Braschel, Caroline, Hannah Fabikan, Vania Mikaela Rodriguez, Maximilian J. Hochmair, Oliver Illini, Leyla Ay, Christoph Weinlinger, Julie Krainer-Jacobs, Nino Müser, Arschang Valipour, and et al. 2026. "Clinical Impact of EGFR Mutation Subtypes on Treatment Outcomes in Advanced Non-Small Cell Lung Cancer: An Austrian Real-World Study" Cancers 18, no. 2: 278. https://doi.org/10.3390/cancers18020278

Braschel, C., Fabikan, H., Rodriguez, V. M., Hochmair, M. J., Illini, O., Ay, L., Weinlinger, C., Krainer-Jacobs, J., Müser, N., Valipour, A., & Krenbek, D. (2026). Clinical Impact of EGFR Mutation Subtypes on Treatment Outcomes in Advanced Non-Small Cell Lung Cancer: An Austrian Real-World Study. Cancers, 18(2), 278. https://doi.org/10.3390/cancers18020278